Effectiveness and Reliability of Hypnosis in Stereotaxy (ERST)
Parkinson Disease, Tremor, Essential, Dystonia, Primary
About this trial
This is an interventional treatment trial for Parkinson Disease focused on measuring Functional neurosurgery, Pain management, Hypnosis, Stereotaxy, Parkinson disease, Essential tremor, Dystonia, Invasive monitoring of epilepsy
Eligibility Criteria
Inclusion Criteria:
- Patients undergoing a stereotactic procedure as listed previously
- Patients ≥ 18 y.o.
Exclusion Criteria:
- Patients < 18 y.o.
- Patients unable to take decisions by their own
- Patients undergoing deep brain stimulation for obsessive-compulsive disease treatment
- Patients refusing to participate to the study
- Pregnancy
- Invasive monitoring of epilepsy
- Psychiatric comorbidity
Sites / Locations
- Geneva University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Hypsnosis
Control
During the fixation of the stereotactic frame, a single hypnosis session is performed by a certified senior anesthesiologist. Blood pressure, heart rate and respiratory rate are continuously monitored by the mean of a regular scope. Pain perceived during and after the procedure is quantifies by the mean of the Visual Analogue Scale (VAS) questionnaire. An open, standardized question will be asked to participants concerning feelings and thoughts about the frame fixation. Answers will be audio recorded. A standardized perceived distress questionnaire (PDI-13) will be performed.
Local anesthesia after clear and complete information of the procedure given the day prior to the surgery. In order to determine the pain perceived during the procedure, a VAS questionnaire will be used, directly after the frame disposal. The rest of the procédure is similar to the hypnosis group.